PrimeRFP SCOUT · Federal Contract Recompete Brief

36C25023N0241Radiopharm — Schaaf Drugs, LLC

Schaaf Drugs, LLC holds $3.7M across 18 federal awards, concentrated at Department of Veterans Affairs (VA). This PIID sits alongside 5 related awards under parent 36C25023D0023. PoP ended Jan 5, 2024 — the usual 12–18 month planning window is closed; recompete action looks late or overdue.

250-Network Contract Office 10 (36C250)

Awarding office

Schaaf Drugs, LLC

Recipient

Jan 5, 2024

PoP end

$114K

Obligated

$605K

Potential

325412

NAICS

6505

PSC

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Schaaf Drugs, LLC — $90

Contract facts

Federal

Contract number36C25023N0241

Also listed as36C250-23-N-0241

Also listed as36C25023D0023-36C25023N0241

Agency250-Network Contract Office 10 (36C250)

Awarding office250-Network Contract Office 10 (36C250)

Awarding agencyDepartment of Veterans Affairs (VA)

Funding agencyDepartment of Veterans Affairs (VA)

IncumbentSchaaf Drugs, LLC

CAGE60B41

UEILSEHGNVLAVX5

NAICS325412

No full NAICS 325412 intel page yet. Browse NAICS intelligence

PSC6505

Parent IDIQ / IDV36C25023D0023

Place of performanceLIMA OH

Pricing typeFirm Fixed Price

Extent competedFull And Open Competition After Exclusion Of Sources

PoP startJan 6, 2023

PoP end (current)Jan 5, 2024

PoP end (w/ options)Jan 5, 2028

Obligated$114K

Current value$114K

Potential value$605K

RADIOPHARM is a federal award for 250-Network Contract Office 10 (36C250) held by Schaaf Drugs, LLC. Estimated value $605K ($114K obligated). Current period of performance ends Jan 5, 2024 (potential Jan 5, 2028). Place of performance: LIMA OH.

Recompete timing

Public

● Past PoP end (959 days ago)

Current PoP ended Jan 5, 2024 (959 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.

Incumbent footprint

Public record

Schaaf Drugs, LLC — $3.7M obligated across 18 awards (firm-wide, all agencies).

Sole agency: Department of Veterans Affairs (VA)

Department of Veterans Affairs (VA)$3.7M · 100% of firm total

Open full company profile →

Related awards

Same parent · incumbent

36C25026N0022

EXERCISING FINAL OY

$3.9M

Sep 30, 2026

36C25025F0010

ORDERING PERIOD OBLIGATION

$2.9M

Sep 30, 2026

36C25023N0050

EXERCISE ORDERING PERIOD 2 RPOC LINE ITEM COMPLIANCE RADIOPHARM FOR THE DAYTON VAMC

$1.3M

Sep 30, 2026

36C25022N0012

RADIOPHARM

$646K

Sep 30, 2026

36C25026N0181

YEAR 4, OPTION YEAR 3 PATIENT RADIOPHARMACEUTICAL DRUGS (12 MONTHS)

$681K

Nov 22, 2026

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract 36C25023N0241?

36C25023N0241 (Radiopharm) is a 250-Network Contract Office 10 (36C250) award with a potential value of $605K, currently held by Schaaf Drugs, LLC. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

What is 36C250-23-N-0241?

36C250-23-N-0241 is the dashed form of PIID 36C25023N0241 (Radiopharm), held by Schaaf Drugs, LLC. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.

Which office awarded 36C25023N0241?

250-Network Contract Office 10 (36C250) awarded 36C25023N0241 to Schaaf Drugs, LLC (potential $605K).

Who is the incumbent on 36C25023N0241?

Schaaf Drugs, LLC is the incumbent with $3.7M across 18 related awards in SCOUT’s public footprint. The current period of performance ends Jan 5, 2024.

When does Schaaf Drugs, LLC’s 36C25023N0241 come up for recompete?

SCOUT tracks a period-of-performance end of Jan 5, 2024. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Jun 25, 2026 · refreshed monthlyLatest procurement action Dec 28, 2022